Statistical analysis of clinical data for patients with GC revealed that sex, age, histological grade, tumor size, T stage and overall cancer stage (Stage I-IV) were not significantly correlated with the Tagln2 expression in ECs. This evidence concerns the gene TAGLN2 and cancer.